Jyseleca® approved in Japan for ulcerative colitis

Approval of additional indication based on Phase 2b/3 SELECTION study in patients with moderate-to-severe ulcerative colitis ...

Related Keywords

Mechelen ,Region Flamande ,Belgium ,Japan ,Tokyo ,United Kingdom ,Northern Ireland ,Craigavon ,Japanese ,Great Britain ,Van Gijsel ,Sandra Cauwenberghs ,Marieke Vermeersch ,Anna Gibbins ,Gilead Sciences ,Gilead Scienceskk Tokyo ,Exchange Commission ,Therapeutic Area Communications ,Ea Pharma Co Ltd ,Eisai Co Ltd ,Japanese Ministry Of Health ,European Union ,Japanese Ministry ,European Summary ,Product Characteristics ,Great Britain Summary ,Northern Ireland Summary ,Private Securities Litigation Reform Act ,Annual Report ,Brussels Stock Exchange Glpg ,Galapagos Nv ,